Scarica l'app Stockscreener
1.66
2.92%
-0.05
Dopo l'orario di chiusura:
1.66
Precedente Chiudi:
$1.71
Aprire:
$1.74
Volume 24 ore:
52,185
Relative Volume:
0.04
Capitalizzazione di mercato:
$20.25M
Reddito:
-
Utile/perdita netta:
-
Rapporto P/E:
-
EPS:
-
Flusso di cassa netto:
-
1 W Prestazione:
-6.21%
1M Prestazione:
-13.99%
6M Prestazione:
-23.15%
1 anno Prestazione:
-96.04%
Intervallo 1D:
$1.62
$1.74
Intervallo di 1 settimana:
$1.62
$1.82
Portata 52W:
$1.345
$53.79
Q 32 Bio Inc Stock (QTTB) Company Profile
Nome
Q 32 Bio Inc
Settore
Industria
Telefono
781-999-0232
Indirizzo
830 WINTER STREET, WALTHAM
Confronta QTTB con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
QTTB
Q 32 Bio Inc
|
1.66 | 20.86M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.93 | 102.81B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
453.54 | 58.59B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
567.22 | 61.25B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
733.66 | 43.23B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
318.73 | 36.53B | 3.81B | -644.79M | -669.77M | -6.24 |
Q 32 Bio Inc Stock (QTTB) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-02-11 | Downgrade | BMO Capital Markets | Outperform → Market Perform |
| 2025-02-11 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2024-12-11 | Downgrade | Guggenheim | Buy → Neutral |
| 2024-12-11 | Downgrade | Leerink Partners | Outperform → Market Perform |
| 2024-12-11 | Downgrade | Raymond James | Strong Buy → Outperform |
| 2024-12-11 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| 2024-12-06 | Iniziato | BMO Capital Markets | Outperform |
| 2024-10-24 | Iniziato | Raymond James | Strong Buy |
| 2024-09-11 | Iniziato | Wells Fargo | Overweight |
| 2024-06-17 | Iniziato | Guggenheim | Buy |
| 2024-05-21 | Iniziato | Leerink Partners | Outperform |
| 2024-04-11 | Iniziato | Oppenheimer | Outperform |
| 2024-04-02 | Iniziato | Piper Sandler | Overweight |
| 2023-07-28 | Downgrade | Robert W. Baird | Outperform → Neutral |
| 2022-02-22 | Reiterato | BTIG Research | Neutral |
| 2022-02-22 | Downgrade | Oppenheimer | Outperform → Perform |
| 2022-02-22 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| 2021-03-02 | Iniziato | Stifel | Hold |
| 2020-12-14 | Ripresa | H.C. Wainwright | Buy |
| 2020-08-11 | Reiterato | H.C. Wainwright | Buy |
| 2020-06-25 | Ripresa | BofA/Merrill | Buy |
| 2020-05-13 | Iniziato | RBC Capital Mkts | Outperform |
| 2020-03-16 | Aggiornamento | Oppenheimer | Perform → Outperform |
| 2020-02-24 | Iniziato | Chardan Capital Markets | Buy |
| 2019-11-01 | Iniziato | Oppenheimer | Perform |
| 2019-09-10 | Iniziato | Robert W. Baird | Outperform |
| 2019-04-12 | Iniziato | Evercore ISI | Outperform |
Mostra tutto
Q 32 Bio Inc Borsa (QTTB) Ultime notizie
Using RSI to spot recovery in Q32 Bio Inc.Quarterly Portfolio Review & Risk Managed Investment Strategies - Newser
How to interpret RSI for Q32 Bio Inc. stockMarket Weekly Review & AI Powered Market Entry Ideas - Newser
Is it too late to sell Q32 Bio Inc.July 2025 Sentiment & Free Reliable Trade Execution Plans - Newser
What moving averages say about Q32 Bio Inc.July 2025 PreEarnings & Growth-Oriented Investment Plans - Newser
Analyzing Q32 Bio Inc. with risk reward ratio chartsOptions Play & Fast Gain Stock Trading Tips - Newser
How much upside does Q32 Bio Inc. haveJuly 2025 Spike Watch & Safe Capital Preservation Plans - khodrobank.com
Order flow analysis tools used on Q32 Bio Inc.Trade Risk Assessment & Daily Chart Pattern Signals - Newser
Can Q32 Bio Inc. keep up with sector leadersQuarterly Growth Report & Fast Moving Stock Watchlists - khodrobank.com
Applying big data sentiment scoring on Q32 Bio Inc.2025 Sector Review & Short-Term High Return Strategies - Newser
Can Q32 Bio Inc. lead its sector in growthJuly 2025 Momentum & AI Forecasted Stock Moves - khodrobank.com
Real time social sentiment graph for Q32 Bio Inc.July 2025 Breakouts & High Yield Equity Trading Tips - Newser
Can Q32 Bio Inc. be recession proofJuly 2025 Setups & High Accuracy Swing Trade Signals - khodrobank.com
Q32 Bio Inc. stock retracement – recovery analysisPortfolio Performance Summary & Free Fast Gain Swing Trade Alerts - Newser
Has Q32 Bio Inc. formed a bullish divergenceRecession Risk & Weekly High Potential Alerts - Newser
Q32 Bio Inc. Volume Confirms Breakout — Analysts Bullish getLinesFromResByArray error: size == 0 - kangso.co.kr
Should you hold or exit Q32 Bio Inc. nowStock Surge & Safe Swing Trade Setups - Newser
Chart based analysis of Q32 Bio Inc. trendsWeekly Profit Recap & Safe Entry Trade Reports - Newser
Sector ETF performance correlation with Q32 Bio Inc.CPI Data & Expert Approved Momentum Ideas - Newser
Is Q32 Bio Inc. stock bottoming out2025 Dividend Review & Free Daily Entry Point Trade Alerts - Newser
Published on: 2025-08-30 19:56:22 - Newser
Using data tools to time your Q32 Bio Inc. exitJuly 2025 Catalysts & Entry and Exit Point Strategies - Newser
Real time scanner hits for Q32 Bio Inc. explained2025 Market WrapUp & Accurate Buy Signal Alerts - Newser
Q32 Bio Inc. stock outlook for YEAREarnings Overview Report & Expert Verified Movement Alerts - Newser
Should you wait for a breakout in Q32 Bio Inc.Market Trend Report & Intraday High Probability Setup Alerts - Newser
Using fundamentals and technicals on Q32 Bio Inc.July 2025 Reactions & Daily Profit Focused Screening - Newser
Q32 Bio Inc. Stock (QTTB) Opinions on Wells Fargo Healthcare Conference Participation - Quiver Quantitative
Q32 Bio to Participate in the 2025 Wells Fargo Healthcare Conference - Eastern Progress
Does Q32 Bio Inc. have declining or rising EPS2025 Market Overview & Precise Swing Trade Alerts - sundaytimes.kr
Price action breakdown for Q32 Bio Inc.Trade Signal Summary & Real-Time Volume Triggers - Newser
CEO’s Surprising Stock Sale Shakes Up Q32 Bio! - TipRanks
Q 32 Bio Inc Azioni (QTTB) Dati Finanziari
Non sono disponibili dati finanziari per Q 32 Bio Inc (QTTB). Controlla altri titoli per ulteriori informazioni.
Reddito
Reddito netto
Flusso di cassa
EPS
Q 32 Bio Inc Azioni (QTTB) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Violette Shelia M. | Chief Scientific Officer |
Aug 26 '25 |
Sale |
1.80 |
2,990 |
5,385 |
58,384 |
| Kalowski Lee | CFO and President |
Aug 26 '25 |
Sale |
1.80 |
4,240 |
7,636 |
49,010 |
| Violette Shelia M. | Chief Scientific Officer |
Oct 15 '24 |
Option Exercise |
7.29 |
6,000 |
43,740 |
23,874 |
| Violette Shelia M. | Chief Scientific Officer |
Oct 11 '24 |
Option Exercise |
3.12 |
4,574 |
14,271 |
17,874 |
| Violette Shelia M. | Chief Scientific Officer |
Oct 08 '24 |
Option Exercise |
3.12 |
13,300 |
41,496 |
13,300 |
1.75%
1.11%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):